Zoledronate Prevents the Development of Absolute Osteopenia Following Ovariectomy in Adult Rhesus Monkeys

This study assessed effects of the bisphosphonate zoledronate (ZLN) on bone density and biochemical markers of bone turnover in ovariectomized (OVX) adult female rhesus monkeys. Forty monkeys were randomly assigned to one control or four OVX groups. The control and one OVX group received saline, and the other three OVX groups received ZLN (0.5, 2.5, or 12.5 μg/kg) by a single weekly subcutaneous injection for 69 weeks. Bone mass of the total body (TB), lumbar spine (LS), distal and central radius (dual‐energy X‐ray absorptiometry), and skeletal turnover markers were measured at baseline and at 13, 26, 39, 52, and 69 weeks of treatment. Increased skeletal turnover and decreased bone mass (LS and TB) were demonstrable by 13 weeks post‐OVX. Maximal bone loss (7–8%) at these sites occurred by 39 weeks after OVX and persisted for the study duration. Long‐term ZLN treatment was well tolerated and prevented increased skeletal turnover and bone loss in a dose‐dependent fashion. Progressive turnover suppression was not observed with any ZLN dose. In conclusion, after OVX, adult rhesus monkeys develop persistent increased bone turnover and absolute osteopenia of the LS and TB, making them an outstanding model of skeletal behavior in perimenopausal women. These OVX‐related skeletal changes are dose‐dependently blocked by ZLN.

[1]  E. Siris,et al.  Antiresorptive Effect of a Single Infusion of Microgram Quantities of Zoledronate in Paget's Disease of Bone , 1997, Calcified Tissue International.

[2]  C. Turner,et al.  Decreased Bone Mass and Strength in Ovariectomized Cynomolgus Monkeys (Macaca fascicularis) , 1997, Calcified Tissue International.

[3]  H. Fleisch,et al.  Bisphosphonates: preclinical aspects and use in osteoporosis. , 1997, Annals of medicine.

[4]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[5]  R. Colman,et al.  The effect of advancing age on bone mineral content of female rhesus monkeys. , 1996, Bone.

[6]  S. Greenspan,et al.  Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy. , 1996, Proceedings of the Association of American Physicians.

[7]  R. Recker,et al.  Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis , 1996 .

[8]  J. Lin,et al.  Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.

[9]  H. Frost.  Perspectives: A proposed general model of the “mechanostat” (suggestions from a new skeletal‐biologic paradigm) , 1996, The Anatomical record.

[10]  D. Weaver,et al.  Development of osteopenia in ovariectomized cynomolgus monkeys (Macaca fascicularis). , 1995, Bone.

[11]  J. Reginster.  The role of bisphosphonates in the prevention and treatment of osteoporosis , 1995, Clinical rheumatology.

[12]  W. Hayes,et al.  Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study. , 1995, The Journal of clinical investigation.

[13]  M Kasra,et al.  Effect of long-term ovariectomy on bone mechanical properties in young female cynomolgus monkeys. , 1994, Bone.

[14]  K. Jaeggi,et al.  Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  M. Adams,et al.  Bone functional changes in intact, ovariectomized, and ovariectomized, hormone‐supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  E. Opas,et al.  The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. , 1993, The Journal of clinical investigation.

[17]  G. Rodan,et al.  The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  K. Gould,et al.  Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. , 1992, The Journal of clinical endocrinology and metabolism.

[19]  D. Collins,et al.  A potential primate model for bone loss resulting from medical oophorectomy or menopause. , 1990, The Journal of clinical endocrinology and metabolism.

[20]  D. Weaver,et al.  Bone Changes in Oophorectomized Monkeys: CT Findings , 1987, Journal of computer assisted tomography.

[21]  R. Recker,et al.  Menopausal changes in calcium balance performance. , 1978, The Journal of laboratory and clinical medicine.

[22]  J. Kalbfleisch.  Statistical Inference Under Order Restrictions , 1975 .

[23]  Morton B. Brown,et al.  The Small Sample Behavior of Some Statistics Which Test the Equality of Several Means , 1974 .

[24]  S. Yeh,et al.  Protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline-induced nephrotoxicity. , 1971, The Journal of pharmacology and experimental therapeutics.

[25]  S. French,et al.  Tetracycline nephrotoxicity and nonoliguric acute renal failure. , 1966, Archives of internal medicine.

[26]  K. Jaeggi,et al.  Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat. , 1998, Arzneimittel-Forschung.

[27]  G. Rodan,et al.  Bone mass homeostasis and bisphosphonate action. , 1997, Bone.

[28]  G. Rodan,et al.  Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae. , 1996, The Journal of pharmacology and experimental therapeutics.

[29]  M. Walker.  Menopause in female rhesus monkeys , 1995, American journal of primatology.

[30]  C. Longcope,et al.  The effect of ovariectomy on spine bone mineral density in rhesus monkeys. , 1989, Bone.

[31]  K. Gould,et al.  Effects of age and sex on bone density in the rhesus monkey. , 1989, Bone.

[32]  Roger Miller,et al.  Design of Experiments A Realistic Approach. , 1975 .

[33]  J. D. Neill,et al.  Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. , 1969, Endocrinology.

[34]  J. D. Neill,et al.  Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. , 1968, Endocrinology.